Role of platelet-rich plasma in management of sensorineural hearing loss diseases | Synapse
March 3, 2026
Role of platelet-rich plasma in management of sensorineural hearing loss diseases
Key Points
The central aim is to evaluate the effectiveness and safety of platelet-rich plasma for treating sensorineural hearing loss.
Evaluation of platelet-rich plasma application in patients with sensorineural hearing loss
Comparison of effects against traditional oral steroid treatments
Assessment of safety and cost-effectiveness
Platelet-rich plasma shows effectiveness in managing sensorineural hearing loss
No systemic side effects were observed unlike those from oral steroids
The treatment is low-cost compared to conventional steroid therapies
Abstract
Platelet-rich plasma appears effective and safe for the management of sensorineural hearing loss with no systemic side effects as an oral steroid and at low cost.